Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Pension: 2009-2024

Historic Pension for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $687.7 million.

  • Fresenius Medical Care AG's Pension fell 569.73% to $687.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $687.7 million, marking a year-over-year decrease of 569.73%. This contributed to the annual value of $734.6 million for FY2024, which is 276.7% up from last year.
  • Fresenius Medical Care AG's Pension amounted to $687.7 million in Q3 2025, which was down 569.73% from $711.8 million recorded in Q2 2025.
  • Fresenius Medical Care AG's Pension's 5-year high stood at $895.3 million during Q4 2021, with a 5-year trough of $524.6 million in Q4 2022.
  • For the 5-year period, Fresenius Medical Care AG's Pension averaged around $691.3 million, with its median value being $704.0 million (2024).
  • As far as peak fluctuations go, Fresenius Medical Care AG's Pension plummeted by 4140.15% in 2022, and later soared by 3624.37% in 2023.
  • Quarter analysis of 5 years shows Fresenius Medical Care AG's Pension stood at $895.3 million in 2021, then tumbled by 41.4% to $524.6 million in 2022, then surged by 36.24% to $714.8 million in 2023, then grew by 1.46% to $725.2 million in 2024, then dropped by 5.17% to $687.7 million in 2025.
  • Its Pension was $687.7 million in Q3 2025, compared to $711.8 million in Q2 2025 and $678.7 million in Q1 2025.